Priority Date: 12.11.10 (US 20100413077P)

Piperidinone carboxamide azaindane CGRP receptor antagonists

  • Application ID: EP14185954
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
7 offices
Technology Company
no operation time available
4 offices
Technology Company
no operation time available
4 offices
Technology Company
no operation time available
4 offices
Technology Company
no operation time available
4 offices
Technology Company
no operation time available
7 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Merck Sharp & Dohme Ltd., Merck & Co. Inc., and Merck Sharp & Dohme Corporation are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 230 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 12.11.2010 - Priority Date (US 20100413077P)
  • 07.01.2015 - Publication A1 (EP2821407)
  • 21.09.2016 - Publication B1 (EP2821407)